Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dedee F Murrell

Showing results (231-240 of 258) with videos related to

Pageof 26
Sort By:
Journal of the American Academy of Dermatology|January 1, 2017
Prospective studies on the routine use of a novel multivariant enzyme-linked immunosorbent assay for the diagnosis of autoimmune bullous diseasesNina van Beek, Cornelia Dähnrich, Nora Johannsen, et al.
The Journal of Investigative Dermatology|August 27, 2010
No evidence that human papillomavirus is responsible for the aggressive nature of recessive dystrophic epidermolysis bullosa-associated squamous cell carcinomaKarin J Purdie, Celine Pourreyron, Hiva Fassihi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 1, 2026
Cumulative isotretinoin dosing, treatment response and acne relapse: A randomized controlled trialRuggero Cascio Ingurgio, Angela Alfano, Antonio Costanzo, et al.
Frontiers in Medicine|November 24, 2018
Perspective From the 5th International Pemphigus and Pemphigoid Foundation Scientific ConferenceJinmin Lee, Victoria P Werth, Russell P Hall, et al.
Journal of the American Academy of Dermatology|April 1, 2008
The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EBJo-David Fine, Robin A J Eady, Eugene A Bauer, et al.
International Journal of Dermatology|January 29, 2025
Quality-of-Life Measurement in Epidermolysis Bullosa. Position Statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient-Oriented Outcomes and External ExpertsPavel V Chernyshov, Andrew Y Finlay, Lucia Tomas-Aragones, et al.
The Journal of Investigative Dermatology|April 10, 2009
Reliability and convergent validity of two outcome instruments for pemphigusMisha Rosenbach, Dedee F Murrell, Jean-Claude Bystryn, et al.
The British Journal of Dermatology|June 6, 2023
Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb studyLeon H Kircik, Javier Alonso-Llamazares, Neal Bhatia, et al.
Journal of the American Academy of Dermatology|April 3, 2014
Inherited epidermolysis bullosa: updated recommendations on diagnosis and classificationJo-David Fine, Leena Bruckner-Tuderman, Robin A J Eady, et al.
International Journal of Dermatology|July 21, 2025
Quality of Life Measurement in Autoimmune Blistering Diseases: Mutual Position Statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Autoimmune Blistering DiseasesPavel V Chernyshov, Andrew Y Finlay, Aikaterini Patsatsi, et al.
Pageof 26

Showing results (231-240 of 258) with videos related to

Sort By:
Pageof 26
Journal of the American Academy of Dermatology|January 1, 2017
Prospective studies on the routine use of a novel multivariant enzyme-linked immunosorbent assay for the diagnosis of autoimmune bullous diseasesNina van Beek, Cornelia Dähnrich, Nora Johannsen, et al.
The Journal of Investigative Dermatology|August 27, 2010
No evidence that human papillomavirus is responsible for the aggressive nature of recessive dystrophic epidermolysis bullosa-associated squamous cell carcinomaKarin J Purdie, Celine Pourreyron, Hiva Fassihi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 1, 2026
Cumulative isotretinoin dosing, treatment response and acne relapse: A randomized controlled trialRuggero Cascio Ingurgio, Angela Alfano, Antonio Costanzo, et al.
Frontiers in Medicine|November 24, 2018
Perspective From the 5th International Pemphigus and Pemphigoid Foundation Scientific ConferenceJinmin Lee, Victoria P Werth, Russell P Hall, et al.
Journal of the American Academy of Dermatology|April 1, 2008
The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EBJo-David Fine, Robin A J Eady, Eugene A Bauer, et al.
International Journal of Dermatology|January 29, 2025
Quality-of-Life Measurement in Epidermolysis Bullosa. Position Statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient-Oriented Outcomes and External ExpertsPavel V Chernyshov, Andrew Y Finlay, Lucia Tomas-Aragones, et al.
The Journal of Investigative Dermatology|April 10, 2009
Reliability and convergent validity of two outcome instruments for pemphigusMisha Rosenbach, Dedee F Murrell, Jean-Claude Bystryn, et al.
The British Journal of Dermatology|June 6, 2023
Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb studyLeon H Kircik, Javier Alonso-Llamazares, Neal Bhatia, et al.
Journal of the American Academy of Dermatology|April 3, 2014
Inherited epidermolysis bullosa: updated recommendations on diagnosis and classificationJo-David Fine, Leena Bruckner-Tuderman, Robin A J Eady, et al.
International Journal of Dermatology|July 21, 2025
Quality of Life Measurement in Autoimmune Blistering Diseases: Mutual Position Statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Autoimmune Blistering DiseasesPavel V Chernyshov, Andrew Y Finlay, Aikaterini Patsatsi, et al.
Pageof 26